Analyze Diet
Journal of veterinary pharmacology and therapeutics2017; 41(2); 184-194; doi: 10.1111/jvp.12450

Review of triazine antiprotozoal drugs used in veterinary medicine.

Abstract: Triazines are relatively new antiprotozoal drugs that have successfully controlled coccidiosis and equine protozoal myeloencephalitis. These drugs have favorably treated other protozoal diseases such as neosporosis and toxoplasmosis. In this article, we discuss the pharmacological characteristics of five triazines, toltrazuril, ponazuril, clazuril, diclazuril, and nitromezuril which are used in veterinary medicine to control protozoal diseases which include coccidiosis, equine protozoal myeloencephalitis, neosporosis, and toxoplasmosis.
Publication Date: 2017-08-17 PubMed ID: 28833212DOI: 10.1111/jvp.12450Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article presents a comprehensive review of triazine antiprotozoal drugs namely, toltrazuril, ponazuril, clazuril, diclazuril, and nitromezuril, primarily used in veterinary medicine to treat diseases caused by protozoa such as coccidiosis, equine protozoal myeloencephalitis, neosporosis, and toxoplasmosis.

Introduction to Triazine Antiprotozoal Drugs

  • Triazines as mentioned in the research report are relatively new antiprotozoal drugs. These are chemotherapeutic agents, specifically structured to combat protozoal diseases predominantly in animals.
  • The mentioned triazines include toltrazuril, ponazuril, clazuril, diclazuril, and nitromezuril. These are used extensively in the field of veterinary medicine to control and treat a few specific protozoal diseases.

Diseases Treatable by Triazine Drugs

  • These triazine drugs have proved successful in controlling diseases like coccidiosis, a parasitic disease of the intestinal tract of animals caused by coccidian protozoa.
  • Equine protozoal myeloencephalitis is another serious disease affecting horses, caused by a protozoa that invades the central nervous system, it can also be effectively treated with these drugs.
  • The report notes that veterinary practitioners have recorded favorable outcomes when treating neosporosis, a parasitic disease caused by Neospora caninum, and toxoplasmosis, a parasitic disease caused by Toxoplasma gondii, using triazine antiprotozoal drugs.

Pharmacological Characteristics of Triazine Drugs

  • The research paper conducts a thorough analysis of the pharmacological aspects of the mentioned triazines, digging deeper into their effects, dosages, adverse effects, pharmacokinetic profile, and their mode of action against protozoa.
  • These findings provide essential details to understand the course of treatment and management of the named diseases, which is crucial in making informed decisions regarding treatment methods in veterinary medicine.

In summary, this review provides important insights into the effectiveness and use of triazine antiprotozoal drugs in veterinary medicine. It presents crucial pharmacological details of these drugs and their efficacy against specified protozoal diseases.

Cite This Article

APA
Stock ML, Elazab ST, Hsu WH. (2017). Review of triazine antiprotozoal drugs used in veterinary medicine. J Vet Pharmacol Ther, 41(2), 184-194. https://doi.org/10.1111/jvp.12450

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 41
Issue: 2
Pages: 184-194

Researcher Affiliations

Stock, M L
  • Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Elazab, S T
  • Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, El-Mansoura, Egypt.
Hsu, W H
  • Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.

MeSH Terms

  • Acetonitriles / therapeutic use
  • Animals
  • Antiprotozoal Agents / therapeutic use
  • Coccidiosis / drug therapy
  • Coccidiosis / veterinary
  • Encephalomyelitis, Equine / drug therapy
  • Encephalomyelitis, Equine / parasitology
  • Encephalomyelitis, Equine / veterinary
  • Horses
  • Nitriles / therapeutic use
  • Protozoan Infections, Animal / drug therapy
  • Toxoplasmosis, Animal / drug therapy
  • Triazines / therapeutic use

Citations

This article has been cited 25 times.
  1. Zhang H, Zhang L, Ren G, Si H, Song X, Liu X, Suo X, Hu D. Forward genetic analysis of monensin and diclazuril resistance in Eimeria tenella. Int J Parasitol Drugs Drug Resist 2023 Aug;22:44-51.
    doi: 10.1016/j.ijpddr.2023.05.002pubmed: 37247559google scholar: lookup
  2. Zhang L, Zhang H, Du S, Song X, Hu D. In Vitro Transcriptional Response of Eimeria tenella to Toltrazuril Reveals That Oxidative Stress and Autophagy Contribute to Its Anticoccidial Effect. Int J Mol Sci 2023 May 6;24(9).
    doi: 10.3390/ijms24098370pubmed: 37176073google scholar: lookup
  3. Onzere CK, Hulbert M, Sears KP, Williams LBA, Fry LM. Tulathromycin and Diclazuril Lack Efficacy against Theileria haneyi, but Tulathromycin Is Not Associated with Adverse Clinical Effects in Six Treated Adult Horses. Pathogens 2023 Mar 14;12(3).
    doi: 10.3390/pathogens12030453pubmed: 36986375google scholar: lookup
  4. Wang W, Ma Y, Zhang Y, Nie J, Hu D, Yang W, Shen Y, Cui X, Ding H, Li L, Huang X. Pharmacokinetics, bioavailability, and excretion of ponazuril in piglets. Front Vet Sci 2022;9:1054417.
    doi: 10.3389/fvets.2022.1054417pubmed: 36570513google scholar: lookup
  5. Sinkó R, Rada K, Kollár A, Mohácsik P, Tenk M, Fekete C, Gereben B. Tetrabromobisphenol A and Diclazuril Evoke Tissue-Specific Changes of Thyroid Hormone Signaling in Male Thyroid Hormone Action Indicator Mice. Int J Mol Sci 2022 Nov 26;23(23).
    doi: 10.3390/ijms232314782pubmed: 36499108google scholar: lookup
  6. Cheng X, Zheng H, Wang C, Wang X, Fei C, Zhou W, Zhang K. Effects of salinomycin and ethanamizuril on the three microbial communities in vivo and in vitro. Front Microbiol 2022;13:941259.
    doi: 10.3389/fmicb.2022.941259pubmed: 36033856google scholar: lookup
  7. Shen H, Li C, Sun H, Chen W, Chen B, Yi Y, Mei J, Zhang Y, Ying G. Generation and Characterization of an Anti-diclazuril Monoclonal Antibody and Development of a Diagnostic Enzyme-Linked Immunosorbent Assay for Poultry. Front Nutr 2022;9:910876.
    doi: 10.3389/fnut.2022.910876pubmed: 35651507google scholar: lookup
  8. Tailor YK, Khandelwal S, Verma K, Gopal R, Kumar M. Multicomponent synthesis of dispiroheterocycles using a magnetically separable and reusable heterogeneous catalyst. RSC Adv 2020 Oct 1;10(60):36713-36722.
    doi: 10.1039/d0ra06676apubmed: 35517964google scholar: lookup
  9. Cox S, Harvill L, Singleton S, Bergman JB, DeBolt B. The influence of storage time on ponazuril concentrations in feline plasma. PeerJ 2021;9:e12516.
    doi: 10.7717/peerj.12516pubmed: 34900432google scholar: lookup
  10. Cheng P, Zhang Z, Yang F, Cai S, Wang L, Wang C, Wang M, Liu Y, Fei C, Zhang L, Xue F, Gu F. FnCas12a/crRNA-Mediated Genome Editing in Eimeria tenella. Front Genet 2021;12:738746.
    doi: 10.3389/fgene.2021.738746pubmed: 34630528google scholar: lookup
  11. Kim E, Park S, Park H, Choi J, Yoon HJ, Kim JH. Determination of Anthelmintic and Antiprotozoal Drug Residues in Fish Using Liquid Chromatography-Tandem Mass Spectrometry. Molecules 2021 Apr 28;26(9).
    doi: 10.3390/molecules26092575pubmed: 33925124google scholar: lookup
  12. Zhang K, Zheng H, Wei S, Wang X, Fei C, Wang C, Liu Y, Zhang L, Xue F, Tang S. Beagle dog 90-day oral toxicity study of a novel coccidiostat - ethanamizuril. BMC Vet Res 2020 Nov 17;16(1):444.
    doi: 10.1186/s12917-020-02655-2pubmed: 33203451google scholar: lookup
  13. Winzer P, Imhof D, Anghel N, Ritler D, Müller J, Boubaker G, Aguado-Martinez A, Ortega-Mora LM, Ojo KK, VanVoorhis WC, Hemphill A. The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite Neospora caninum and Re-infected During Pregnancy. Front Vet Sci 2020;7:587570.
    doi: 10.3389/fvets.2020.587570pubmed: 33195616google scholar: lookup
  14. Winzer P, Müller J, Imhof D, Ritler D, Uldry AC, Braga-Lagache S, Heller M, Ojo KK, Van Voorhis WC, Ortega-Mora LM, Hemphill A. Neospora caninum: Differential Proteome of Multinucleated Complexes Induced by the Bumped Kinase Inhibitor BKI-1294. Microorganisms 2020 May 26;8(6).
    doi: 10.3390/microorganisms8060801pubmed: 32466554google scholar: lookup
  15. Li X, Chen H, Zhao Q, Zhang L, Zhang K, Wang X, Wang M, Liu Y, Wang C, Xue F, Fei C. Preliminary study of the mechanism of action of ethanamizuril against Eimeria tenella. Parasitol Res 2020 May;119(5):1653-1661.
    doi: 10.1007/s00436-020-06665-9pubmed: 32219548google scholar: lookup
  16. Li XY, Liu LL, Zhang M, Zhang LF, Wang XY, Wang M, Zhang KY, Liu YC, Wang CM, Xue FQ, Fei CZ. Proteomic analysis of the second-generation merozoites of Eimeria tenella under nitromezuril and ethanamizuril stress. Parasit Vectors 2019 Dec 18;12(1):592.
    doi: 10.1186/s13071-019-3841-9pubmed: 31852494google scholar: lookup
  17. Zálešák F, Slouka J, Stýskala J. General Synthesis of 1-Aryl-6-azaisocytosines and Their Utilization for the Preparation of Related Condensed 1,2,4-Triazines. Molecules 2019 Oct 1;24(19).
    doi: 10.3390/molecules24193558pubmed: 31581428google scholar: lookup
  18. Scheltema E, Singh P, Howe L, Godfrey AJR, Wilkinson B, Pipe V, Morgan K. Efficacy of prophylactic dosing of diclazuril for the prevention of coccidiosis in captive-reared North Island brown kiwi (Apteryx mantelli) chicks. Parasitol Res 2026 Jan 6;125(1):3.
    doi: 10.1007/s00436-025-08572-3pubmed: 41495466google scholar: lookup
  19. Wang S, Zhang L, Hong F, Du W, Ke C, Wan JP. Recent Advances in C-H Perfluoroalkyl Thiolation and Perfluoroalkyl Sulfonylation. ACS Org Inorg Au 2025 Dec 3;5(6):467-484.
    doi: 10.1021/acsorginorgau.5c00094pubmed: 41356456google scholar: lookup
  20. Wang C, Yin R, Jiang H, Ma Q, Zhang H, Zheng S, Yu R, Liu H, Li X, Jiang T. Achieving cysteine-selective peptide/protein bioconjugation via tunable triazine-pyridine chemistry. Sci Adv 2025 Dec 5;11(49):eaea6904.
    doi: 10.1126/sciadv.aea6904pubmed: 41337588google scholar: lookup
  21. Scuotto A, Ogonczyk-Makowska D, Quiévy A, Berthet M, Schlax K, Boussarie D, Maillot A, Popelin-Wedlarski F, Charpentier T, Perot M, Quintard B, van Elderen M, Stumpel JBG, Tahas SA, Modlinska A, Sós-Koroknai V, Azevedo A, Muciño MDCC, Martins MC, Madrid C, Stadlin JP, Henao-Montoya LM, Betbeder D. Retrospective Analysis of the Impact of Vaccination with an Inactivated Vaccine on Toxoplasmosis-Associated Mortality in Captive Wildlife. Vaccines (Basel) 2025 Aug 27;13(9).
    doi: 10.3390/vaccines13090910pubmed: 41012115google scholar: lookup
  22. Gu X, Fang S, Liu H, Shi Y, Zhang Y, Wang P, Cui P, Tang X. Genomic insights into monensin resistance development in Eimeria tenella. Front Vet Sci 2025;12:1459791.
    doi: 10.3389/fvets.2025.1459791pubmed: 40235566google scholar: lookup
  23. El-Sawah AA, Aboelhadid SM, El-Nahass EN, Helal HE. Efficacy and safety of diclazuril nanoemulsion in control of Eimeria tenella in broilers. BMC Vet Res 2024 Oct 29;20(1):495.
    doi: 10.1186/s12917-024-04325-zpubmed: 39472852google scholar: lookup
  24. Chen H, Dai Y, Liu J, Duan L, Hu J, Sun S, Zhu G, Ma X, Wan J, Ma N, Zhang X, Wang C, Zhao N. Anti-Eimeria tenella activity of Ethanamizuril in vitro and in vivo. J Vet Med Sci 2024 Sep 20;86(9):1008-1015.
    doi: 10.1292/jvms.24-0223pubmed: 39069485google scholar: lookup
  25. Johansen Å, Lin J, Yamada S, Mohamed-Ahmed S, Yassin MA, Gjerde C, Hutchinson DJ, Mustafa K, Malkoch M. Photo-Clickable Triazine-Trione Thermosets as Promising 3D Scaffolds for Tissue Engineering Applications. Adv Healthc Mater 2024 Oct;13(27):e2401202.
    doi: 10.1002/adhm.202401202pubmed: 39021283google scholar: lookup